BIO - CAS 667463-62-9
Catalog number: 667463-62-9
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C16H10BrN3O2
Molecular Weight:
356.17
COA:
Inquire
Targets:
CDK
Description:
BIO (6-bromoindirubin-3'-oxime) is a specific inhibitor of GSK-3 with IC50 of 5 nM for GSK-3α/β, shows >16-fold selectivity over CDK5, also a pan-JAK inhibitor.
Purity:
>98%
Synonyms:
BIO; ​GSK3 Inhibitor IX; MLS 2052; MLS-2052; MLS2052.
MSDS:
Inquire
InChIKey:
WNWSUJQVZJJGLF-UHFFFAOYSA-N
InChI:
InChI=1S/C16H10BrN3O2/c17-8-5-6-9-12(7-8)19-16(21)13(9)15-14(20-22)10-3-1-2-4-11(10)18-15/h1-7,20,22H,(H,19,21)
Canonical SMILES:
C1=CC2=C(C(=C3C4=C(C=C(C=C4)Br)NC3=O)N=C2C=C1)NO
1.A novel pyrene based fluorescent probe for selective detection of cysteine in presence of other bio-thiols in living cells.
Rani BK1, John SA2. Biosens Bioelectron. 2016 Apr 7;83:237-242. doi: 10.1016/j.bios.2016.04.013. [Epub ahead of print]
This manuscript reports the synthesis of pyrene-based fluorescent probe (PA-1) containing α,β-unsaturated carbonyl moiety and its application towards the selective and sensitive detection of cysteine (Cys) over other bio-thiols. The probe, 3-(2-hydroxyphenyl)-1-pyrenyl-2-propenone (PA-1) was synthesized through Claisen-Schmidt condensation between acetyl pyrene and salicylaldehyde. The formed product was characterized by 1H NMR, 13C NMR and GC-MS techniques. The probe exhibited absorption maximum at 374nm and emission maximum at 467nm (λex=342nm). The emission intensity of PA-1 was greatly enhanced while adding 2.5nM Cys. This can be attributed to the nucleophilic attack of Cys to the α,β-unsaturated ketone resulting in switching off, intramolecular charge transfer (ICT) from pyrene moiety to the phenolic nucleus. This was confirmed by DFT measurements. The PA-1 exhibited an excellent selectivity towards the determination of 40nM cys in the presence of 250,000-fold higher concentration of common interferents.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related CDK Products


CAS 1604810-83-4 THZ1

THZ1
(CAS: 1604810-83-4)

THZ1 is a selective CDK7 inhibitor that preferentially diminishes transcription in cancer cells. THZ1 has the unprecedented ability to target a remote cysteine ...

CAS 1231930-82-7 abemaciclib mesylate

abemaciclib mesylate
(CAS: 1231930-82-7)

Abemaciclib mesylate is a CDK inhiibitor with selectivity for CDK4 and CDK6. It was approved for the treatment of advanced or metastatic breast cancers.

CAS 153437-55-9 WHI-P180 hydrochloride

WHI-P180 hydrochloride
(CAS: 153437-55-9)

WHI-P180 moderately inhibited ABCG2 function, exhibiting weak phototoxicity. The elimination half-life of WHI-P180 in CD-1 mice (BALB/ c mice) following i.v., i...

CAS 902135-91-5 AT7519 HCl

AT7519 HCl
(CAS: 902135-91-5)

AT-7519 is an orally bioavailable small molecule CDK inhibitor with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependen...

CAS 844442-38-2 AT-7519

AT-7519
(CAS: 844442-38-2)

AT-7519 is an orally bioavailable small molecule CDK inhibitor with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependen...

CAS 199986-75-9 CVT-313

CVT-313
(CAS: 199986-75-9)

A cell-permeable purine analog that acts as a potent, selective, reversible, and ATP-competitive inhibitor of Cdk2 (IC50 = 0.5 µM for Cdk2/A and Cdk2/E; 4.2 µM ...

CAS 571189-11-2 PD 0332991 hydrochloride

PD 0332991 hydrochloride
(CAS: 571189-11-2)

PD 0332991 hydrochloride is a cyclin-dependent kinase (CDK) inhibitor with high affinity for CDK4 and CDK6. It has the potential for breast cancer treatment.

CAS 265312-55-8 Ryuvidine

Ryuvidine
(CAS: 265312-55-8)

Ryuvidine, a cell-permeable dioxobenzothiazole compound, is an inhibitor of SETD8 (IC50 = 0.5 µM) that suppresses monomethylation of H4K20 in vitro.1 It less po...

Chemical Structure

CAS 667463-62-9 BIO

Quick Inquiry

Verification code

Featured Items